What's happening
This bill adds W-18 to New York's list of Schedule I controlled substances, making its possession and distribution illegal.
Why it matters
W-18 is an extremely potent synthetic opioid. adding it to Schedule I means New York is responding to concerns over its high risk for abuse, overdose, and death, similar to the dangers posed by fentanyl and related substances.
Criminal penalties for possessing or distributing W-18 will now match those for other Schedule I drugs. , which serves as both a deterrent and a prosecutorial tool against dealers and traffickers in the state.
Including W-18 on the controlled substances list allows law enforcement and public health agencies to track, seize, and respond to its presence more effectively. , potentially preventing its spread in New York's illicit drug market before it becomes widespread.
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Who cares
Law enforcement agencies and prosecutors
The bill would add W-18 to Schedule I of New York’s controlled substances law.
Chemical suppliers handling W-18
The bill would make W-18 a Schedule I controlled substance, changing its legal classification.
Researchers working with W-18
The bill would place the substance they study under Schedule I controls immediately upon taking effect.
Headline styles
Add W-18 to Controlled Substances
Plain English, a few words. Used as the page title.
Sponsors
Senator · Senate District 39
1 Co-sponsor
History
- Referred to health
- Referred to health
Companion bill
The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.
Add W-18 to Controlled Substances
In Assembly Committee · Health · Sponsor Edward Braunstein
Full text
1 pageUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗
STATE OF NEW YORK
1774
2021-2022 Regular Sessions
IN SENATE
January 15, 2021
Introduced by Sens. SKOUFIS, KAPLAN -- read twice and ordered printed, and when printed to be committed to the Committee on Health
AN ACT to amend the public health law, in relation to adding W-18 to the schedule of controlled substances
The People of the State of New York, represented in Senate and Assembly, do enact as follows:
Section 1. Subdivision (b) of schedule I of section 3306 of the public health law is amended by adding a new paragraph 71 to read as follows:
(71) W-18 (4-chloro-N-{1-{2-(4-nitrophenyl)ethyl}2piperidinylidene}benzenesulfonamide).
§ 2. This act shall take effect immediately.
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD03482-01-1
Reflowed for reading: line numbers and page breaks removed. Cite the official text.
Sponsor's memo
Title of bill
An act to amend the public health law, in relation to adding W-18 to the schedule of controlled substances
Purpose
Relates to adding W-18 to the schedule of controlled substances
Summary of provisions
Section 1 adds W-18 (4-chloro-N-(1-{2-(4-nitrophenyl)ethy1}2- piperidinylidenelbenzenesulfonamide to Subdivision (b) of Schedule I of Section 3306 of the Public Health Law.
Section 2 provides the effective date.
Justification
In recent years, the use of synthetic drugs has become increasingly widespread. These drugs have been created by manufacturers as an alter- native to already-illegal drugs. This legislation would make W18 illegal in order to prevent the potentially harmful results of W18 from reaching New York.
W-18, which was banned in Canada in 2016, was originally created as a pain reliever and patented in the United States and Canada in 1984, but was only tested on mice and never sold commercially. The 1984 patent for W-18 indicated that there were no tests which could detect the drug in blood or urine. According to the Canadian Department of Health, "the use of W-18 as a legal substitute for other controlled substances was first detected in Europe in 2013, in the context of recreational use. In 2014,W-18 was added to the Europe an Monitoring Centre for Drugs and Addiction (EMCDDA) list of New Psychoactive Substances." W-18 first appeared in Canada in 2015 in counterfeit oxycodone tablets. Health Canada also indicates that "the high analgesic potency of W-18...suggests a potential severe risk for overdose" and the drug is being imported from drug labs in China.
The Washington Post reported in 2016 that some experts indicate that W-18 is 100 times more potent than fentanyl and 10,000 times stronger than morphine. A portion of W-18 the size of a grain of salt could potentially be deadly, according to WYSR in Syracuse. While more research is needed to prove the level of toxicity in W-18, police departments in Canada indicate that it has been mixed with heroin and cocaine to create a more dangerous synthetic drug.
In March, 2016, a drug dealer in Florida was convicted of smuggling fentanyl and law enforcement found more than 2 1/2 pounds of W-18 at his residence.
Legislative history
2020 - S5221 Referred to Health Assembly
2020 - A509 Referred to Health 2017-2018: A.3030/S.5112 - Referred to Health.
Fiscal implications
None.
Effective date
This act shall take effect immediately.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.